An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial
Year: 2025
Type: article
Study design: Clinical Trial
Source: Science Translational Medicine
Institutions: Vaxart (United States), University of Maryland, Baltimore
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4408245030
